🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Treatment of Negative Symptoms of Schizophrenia by rTMS

RecruitingNAAges 18 Years - anyAllCentre hospitalier de Ville-Evrard, France
NCT06595654 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient over 18 years of age * Patient diagnosed with schizophrenia according to the DSM-V criteria (Diagnostic and Statistical Manual of Mental Disorder V5, 2013) * Stable drug treatment for at least 4 weeks * Presence or persistence of negative symptoms in the foreground: Negative PANSS score ⩾21, positive PANSS score ⩽24 * Patient (or legal representative) willing to participate in the study and having signed an informed consent * Patient fluent in the French language * Affiliation to a social security scheme Exclusion Criteria: * Present a contraindication to TMS: intracranial foreign body, unstabilized epilepsy, cochlear implant, pace-maker * Presence of an unstabilized medical condition * Pregnant woman * Woman of childbearing potential and without effective contraception * Breastfeeding woman
💊

What it tests

  • repetitive Transcranial Magnetic Stimulation
📍

Where

1 site
Etablissement Public de Santé de Ville-Evrard
Neuilly-sur-Marne, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy